Dose Escalation, Safety and Pharmacokinetic Study of AVE8062 Combined With Docetaxel in Patients With Advanced Solid Tumors

Clinical trial NCT01907685 · COMPLETED

Trial details

NCT number: NCT01907685
Sponsor: Sanofi
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Neoplastic Disease

Start date: 2006-06-01
Primary completion: 2011-02-01
Enrollment: 58

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.